25 May, 2021
Refractive laser surgery is one of the best known and most commonly performed options for correcting vision problems and can be an alternative to wearing glasses or contact lenses. Now, the barnaclínic+ Ophthalmology service that carries out this type of surgery, has incorporated into its facilities a new system that utilises two types of laser: the femtosecond laser to make a precise cut in the form of a window in the cornea (the transparent dome-shaped part at the front of the eye) and the excimer laser to modify its curvature.
Thanks to the new equipment it will be possible to carry out two surgical procedures. On is the technique known as FEMTO-LASIK (laser-assisted in situ keratomileusis) and the other is PRK (photorefractive keratectomy). “Thanks to these techniques we will be able to correct both myopia and hyperopia or astigmatism. They are all about pathologies in which there is a malformation in the length of the eyeball or in the shape of the curve that can be corrected with the laser”, explains Dr Jorge Peraza, an expert ophthalmologist in refractive surgery of barnaclínic+.
21 May, 2021
On May 12, as usual, the Hospital Clínic held an act to commemorate International Nurses Day. On this occasion, and due to the situation of the COVID-19 pandemic, it was broadcasted via streaming through its YouTube channel. This act served to publicise the different projects that have received an Intensification Grant, which are financed by barnaclínic+.
It is an initiative of the Directorate of Nursing of the Hospital Clínic de Barcelona, which aims to improve the care activity of the centre by training and promoting the research of nursing professionals. It lasts between 3 and 6 months and it is awarded to a group of professionals who are selected following a series of criteria. These scholarships were launched in 2016 and since then they have been a success, which is why barnaclínc+ continues to bet on them.
20 May, 2021
The Hospital Clínic is a reference centre in Spain when it comes to kidney transplants. On July 27, 1965, doctors Josep María Gil-Verat and Antoni Caralps completed the first kidney transplant in Spain. In all the time that has elapsed since then, 5,000 transplant operations have been carried out in the centre, of which 1,000 have been from a living donor, being the first centre in our country to achieve this figure. Some numbers that undoubtedly serve to highlight the transcendental role that the centre plays in our country with regard to kidney transplants.
25 March, 2021
Greater precision in surgery and reduced risks and complications during interventions result in better outcomes for patients. This is what robotic surgery provides, one of the great advances that technological developments in medicine have made possible in recent years. One of the centres that has made the most significant commitment to this type of surgery is the Hospital Clínic Group and barnaclínic+.
9 March, 2021
New equipment acquired by the Hospital Clínic Group allows for both early planning that is more adapted to each specific case, as well as assistance during surgery to improve its precision and accuracy. Thanks to this increased customisation and precision, patient recovery is better and faster and the knee prosthesis is also more durable.
3 March, 2021
The Hospital Clínic Group has recently acquired new interstitial laser equipment for its Epilepsy Unit. This minimally invasive technology can be used, among other things, to treat those types of epilepsy that do not respond to conventional pharmacological treatments and which account for 30% of all patients with epilepsy.
16 February, 2021
The AEMPS approves the use of a CAR-T therapy developed by the Hospital Clínic Group for the treatment of a type of leukaemia
In recent years, cancer treatment has been revolutionised by immunotherapy, an approach that uses a patient’s own immune system to attack tumour cells. The Spanish Agency of Medicines and Medical Devices (AEMPS) has just approved ARI-0001, a CAR T-cell therapy (a type of immunotherapy) developed entirely by the Hospital Clínic Group, for use as a medicinal product. This is the first time that a treatment with genetically modified cells developed entirely in Europe has been approved by a regulatory agency, and it is also the first time that it has been done without the backing of a pharmaceutical company.
10 February, 2021
A new molecular test detects genetic abnormalities in tumours and improves customised cancer diagnosis and treatment
At the Grupo Hospital Clínic, we have a new option for diagnosis of advanced cancer. It is a new test using Next Generation Sequencing (NGS) technology which, by analysing the tumour’s DNA and RNA, detects multiple genetic abnormalities in 52 of your genes. This new cancer diagnostic test allows your treatment to be further customised. In addition, it improves current tests for the diagnosis of lung, colon and rectal cancer and melanoma.
21 December, 2020
On December the 10th, the new surgical area of the Clinical Institute of Ophthalmology (ICOF), of the Hospital Clínic de Barcelona Group, was inaugurated. These are facilities that have the latest technology in this speciality and allow highly complex surgical treatments; with better results, greater precision and better post-operative services. In addition, with the construction of the Eye Training Centre Clinic, the Ophthalmology Service will combine surgical, educational and training activities in a single space.
11 December, 2020
On October 5th, a multidisciplinary team from the Hospital Clínic Group performed the first uterus transplant in Spain. The surgery was led by Dr. Francisco Carmona, head of the Gynecology Service at the Hospital Clínic and gynecological surgeon at barnaclínic+, and Dr. Antonio Alcaraz, head of the Urology and Kidney Transplant Service at the Clínic and urological and transplant surgeon at barnaclínic+ . This first live donor uterus transplant from Spain has been possible thanks to the donation of this organ from one sister to another, who was born without it, and which is known as Rokitansky Syndrome.